Mitochondrial gene therapy: AAV2-mediated direct delivery of nucleic acids to the mitochondrial matrix as a treatment for Lebers Hereditary Optic Neuropathy

被引：0
|
作者：
Huston, M. W. [1 ]
Mastroberardino, P. G. [2 ]
Wagemaker, G. [3 ]
de Coo, I. F. M. [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands
[3] Hacettepe Univ, Stem Cell Res Ctr, Ankara, Turkey
来源：
HUMAN GENE THERAPY | 2014年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P153
引用
收藏
页码：A105 / A105
页数：1
相关论文
共 32 条
  • [21] Efficient Transduction of Tyrosine-to-Phenylalanine Mutated AAV2 Vectors Carrying Human ND4 Gene and Biodistribution Following Intravitreal Delivery in a Rodent Model - A Gene Therapy for Leber Hereditary Optic Neuropathy
    Koilkonda, Rajeshwari D.
    Hauswirth, William W.
    Chiodo, Vince
    Boye, Sanford L.
    Guy, John
    MOLECULAR THERAPY, 2012, 20 : S169 - S169
  • [22] Lenadogene nolparvovec rAAV2 gene therapy vector encoding ND4 Treatment of Leber hereditary optic neuropathy
    Desideri, Lorenzo Ferro
    Traverso, Carlo Enrico
    Iester, Michele
    DRUGS OF THE FUTURE, 2022, 47 (06) : 429 - 433
  • [23] Mitochondrial Gene Therapy Improves Respiration, Biogenesis, and Transcription in G11778A Leber's Hereditary Optic Neuropathy and T8993G Leigh's Syndrome Cells
    Iyer, Shilpa
    Bergquist, Kristen
    Young, Kisha
    Gnaiger, Erich
    Rao, Raj R.
    Bennett, James P., Jr.
    HUMAN GENE THERAPY, 2012, 23 (06) : 647 - 657
  • [24] Safety, local tolerability and biodistribution of GS010 (AAV2/2-ND4), a gene therapy medicinal product in development for Leber Hereditary Optic Neuropathy (LHON)
    Thomasson, Nitza
    Cwerman-Thibault, Helene
    Augustin, Sebastien
    Simonuti, Manuel
    Sahel, Jose-Alain
    Pruneau, Didier
    Montus, Marie
    Galy, Anne
    Corral-Debrinski, Marisol
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [25] Phase I Gene Therapy Preliminary Clinical Results for Treatment of ND4 Leber Hereditary Optic Neuropathy with rAAV2-2-ND4
    Uretsky, Scott
    Vignal, Catherine
    Bidot, Samuel
    Fitoussi, Serge
    Galy, Anne
    Meunier, Sandrine
    Noel, Roxane
    Bouquet, Celine
    Thomasson, Nitza
    Combal, Jean-Philippe
    Sahel, Jose A.
    MOLECULAR THERAPY, 2016, 24 : S106 - S106
  • [26] Intravitreal rAAV2/2-ND4 (GS010): A gene therapy for vision loss in Leber's Hereditary Optic Neuropathy (LHON) caused by the G11778A ND4 mitochondrial mutation
    Uretsky, Scott
    Vignal, Catherine
    Thomasson, Nitza
    Bouquet, Celine
    Galy, Anne
    Combal, Jean Philipppe
    Fitoussi, Serge
    Sahel, Jose-Alain
    NEUROLOGY, 2017, 88
  • [27] Assessment of Neutralizing Antibodies Against Adeno-associated virus (AAV)2 Capsids in Serum and Ocular Fluid Samples of Leber' Hereditary Optic Neuropathy (LHON) Gene Therapy Clinical Trial Patients
    Koilkonda, Rajeshwari D.
    Feuer, William J.
    Schiffman, Joyce C.
    Davis, Janet L.
    Porciatti, Vittorio
    Gonzalez, Phillip
    Lam, Byron L.
    Guy, John
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [28] Gene Delivery of ATP6 by A Mitochondrial Targeting Sequence Modification of AAV Capsid VP2 Rescues Cells with Mutated T8993G MtDNA Responsible for Neuropathy Ataxia and Retinitis Pigmentosa
    Yuan, Huijun
    Yu, Hong
    Guy, John
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [29] Mitochondrial Gene Delivery of Wild-Type ATP6 Mediated by a Mitochondrial Targeting Sequence Modification to AAV Capsid VP2 Rescues Cells with Mutated T8993G MtDNA Responsible for Maternally Inherited Leigh Syndrome and Neurogenic Ataxia and Retinitis Pigmentosa
    Guy, John
    Yuan, Huijuan
    NEUROLOGY, 2013, 80
  • [30] Relevance of NHP safety studies for ocular delivery of AAV-based gene therapy in humans: Example of GS010 (rAAV2/2-ND4) local tolerability, shedding and immunogenicity for the treatment of Leber Hereditary Optic Neuropathy (LHON), after intravitreal (IVT) injection in non-human primates (NHP) and in LHON patients
    Thomasson, Nitza
    Galy, Anne
    Fitoussi, Serge
    Meunier, Sandrine
    Uretsky, Scott
    Combal, Jean-Philippe
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
1234